Back to ACAD
Ishara Investments LP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
4
Latest value
$6.4M
Q3 2026
Peak value
$10.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $4.3M |
| Q1 2026 | $2.7M |
| Q2 2026 | $10.4M |
| Q3 2026 | $6.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.4M | 320.0K | — | — |
| Q2 2026 | $10.4M | 410.0K | — | — |
| Q1 2026 | $2.7M | 123.0K | — | — |
| Q4 2025 | $4.3M | 160.0K | — | — |
Other funds holding ACAD
$954.9M
$864.7M
$386.3M
$383.2M
$377M
$323.1M